ZA767579B - Trifluoromethyltio(and sulfonyl)derivatives of cyprohertadine analogs - Google Patents

Trifluoromethyltio(and sulfonyl)derivatives of cyprohertadine analogs

Info

Publication number
ZA767579B
ZA767579B ZA00767579A ZA767579A ZA767579B ZA 767579 B ZA767579 B ZA 767579B ZA 00767579 A ZA00767579 A ZA 00767579A ZA 767579 A ZA767579 A ZA 767579A ZA 767579 B ZA767579 B ZA 767579B
Authority
ZA
South Africa
Prior art keywords
trifluoromethyltio
cyprohertadine
sulfonyl
analogs
derivatives
Prior art date
Application number
ZA00767579A
Other languages
English (en)
Inventor
D Remy
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA767579B publication Critical patent/ZA767579B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02Magnesium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00767579A 1975-12-22 1976-12-21 Trifluoromethyltio(and sulfonyl)derivatives of cyprohertadine analogs ZA767579B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,863 US4031222A (en) 1975-12-22 1975-12-22 Trifluoromethylthio (and sulfonyl) derivatives of cyproheptadine analogs

Publications (1)

Publication Number Publication Date
ZA767579B true ZA767579B (en) 1978-08-30

Family

ID=24578354

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00767579A ZA767579B (en) 1975-12-22 1976-12-21 Trifluoromethyltio(and sulfonyl)derivatives of cyprohertadine analogs

Country Status (26)

Country Link
US (1) US4031222A (xx)
JP (1) JPS5278880A (xx)
AT (1) AT363936B (xx)
AU (1) AU506996B2 (xx)
BE (1) BE849678A (xx)
CA (1) CA1085823A (xx)
CH (7) CH625790A5 (xx)
DE (1) DE2657978C3 (xx)
DK (1) DK550976A (xx)
ES (6) ES454468A1 (xx)
FI (1) FI763545A (xx)
FR (1) FR2336133A1 (xx)
GB (1) GB1519080A (xx)
GR (1) GR62010B (xx)
HU (1) HU175018B (xx)
IE (1) IE44362B1 (xx)
IL (1) IL51103A (xx)
LU (1) LU76382A1 (xx)
NL (1) NL7613713A (xx)
NO (1) NO146359C (xx)
NZ (1) NZ182868A (xx)
PH (1) PH14088A (xx)
PL (4) PL116941B1 (xx)
PT (1) PT65956B (xx)
SE (1) SE7613796L (xx)
ZA (1) ZA767579B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148903A (en) * 1977-07-28 1979-04-10 Merck & Co., Inc. Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines
US4132796A (en) * 1977-12-01 1979-01-02 Merck & Co., Inc. Antipsychotic 3-trifluoromethylsulfinyl analogs of cyproheptadine
US4285956A (en) * 1978-05-12 1981-08-25 Kefalas A/S Xanthene and thioxanthene derivatives, compositions thereof and treatment therewith
US4195091A (en) * 1978-11-15 1980-03-25 Merck & Co., Inc. Appetite stimulating pyrrolo[2,1-b][3]benzazepines
EP0012988B1 (en) * 1979-01-02 1983-04-27 Merck & Co. Inc. Levorotatory or dextrorotatory enantiomers of 3-halocyproheptadines, process for their preparation and pharmaceutical composition thereof
US4275070A (en) * 1979-05-21 1981-06-23 Merck & Co., Inc. Antipsychotic pharmaceutical compositions of the levorotatory enantiomers of 3-methoxycyproheptadine and an analog thereof
US4220651A (en) * 1979-05-21 1980-09-02 Merck & Co., Inc. Antipsychotic levorotatory enantiomers of 3-halocyproheptadines, analogs and derivatives
EP0019797A1 (en) * 1979-05-21 1980-12-10 Merck & Co. Inc. Levorotatory and dextrorotatory enantiomers of 3-methoxycyproheptadine and analogs thereof, process for their preparation and antipsychotic pharmaceutical compositions
US5231105A (en) * 1987-06-02 1993-07-27 Ajinomoto Co., Inc. Ethylamine derivatives and antihypertensives containing the same
US5393890A (en) 1988-06-02 1995-02-28 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
US4996321A (en) * 1990-02-26 1991-02-26 Merck & Co., Inc. Dibenzo[a,d]cycloheptenylidene compounds
US5021426A (en) * 1990-02-26 1991-06-04 Merck & Co., Inc. Method of traeting malaria with cyproheptadine derivatives
CN103130708B (zh) * 2011-12-01 2016-08-10 上海药明康德新药开发有限公司 一种n-叔丁氧羰基-4-硝基哌啶的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3851059A (en) * 1970-02-05 1974-11-26 Merck & Co Inc Method for the stimulation of appetite in patients

Also Published As

Publication number Publication date
NO146359C (no) 1982-09-15
ES466549A1 (es) 1978-10-01
AT363936B (de) 1981-09-10
ATA943376A (de) 1981-02-15
CH626344A5 (xx) 1981-11-13
IL51103A (en) 1980-11-30
DE2657978B2 (de) 1980-06-04
HU175018B (hu) 1980-04-28
CA1085823A (en) 1980-09-16
PH14088A (en) 1981-02-10
IL51103A0 (en) 1977-02-28
PT65956B (en) 1978-11-07
US4031222A (en) 1977-06-21
PL116947B1 (en) 1981-07-31
ES466553A1 (es) 1978-10-01
PL116346B1 (en) 1981-06-30
FR2336133B1 (xx) 1978-11-17
ES466551A1 (es) 1978-10-01
BE849678A (fr) 1977-06-21
CH631164A5 (de) 1982-07-30
FR2336133A1 (fr) 1977-07-22
GR62010B (en) 1979-02-15
IE44362L (en) 1977-06-22
AU506996B2 (en) 1980-01-31
CH626345A5 (xx) 1981-11-13
ES466550A1 (es) 1978-10-01
NZ182868A (en) 1979-03-28
PT65956A (en) 1977-01-01
IE44362B1 (en) 1981-11-04
NL7613713A (nl) 1977-06-24
GB1519080A (en) 1978-07-26
NO146359B (no) 1982-06-07
CH627167A5 (xx) 1981-12-31
ES454468A1 (es) 1978-04-16
PL122145B1 (en) 1982-06-30
NO764188L (xx) 1977-06-23
PL116941B1 (en) 1981-07-31
CH625790A5 (xx) 1981-10-15
CH626343A5 (xx) 1981-11-13
LU76382A1 (xx) 1977-06-28
CH626346A5 (xx) 1981-11-13
AU2052876A (en) 1978-06-22
JPS5278880A (en) 1977-07-02
DK550976A (da) 1977-06-23
PL194577A1 (xx) 1980-01-28
DE2657978C3 (de) 1981-02-12
FI763545A (xx) 1977-06-23
ES466552A1 (es) 1978-10-01
DE2657978A1 (de) 1977-06-23
SE7613796L (sv) 1977-06-23

Similar Documents

Publication Publication Date Title
IL50599A0 (en) Novel derivatives of benzhydrylsulfinyl
JPS5283331A (en) Nnthiolcarbonyl derivatives of nnphosphonomethylglycin
GB1542940A (en) Dihydroimidazopyridinones and derivatives of such compounds
PH14088A (en) Trifluorometrylthio(and sulfonyl)derivatives of cycloheptadine analogs
NZ180785A (en) Preparation of 5-aroyl-1-lower alkylpyr-rolf-2-acetic acid derivatives
JPS51136772A (en) Preparation of high ciss1*44polybutadiene
JPS51131836A (en) Preparation of acetoacetylarylamide
JPS5251330A (en) Preparation of trichloromethyll trifluoromethyllbenzene
JPS51115427A (en) Preparation of ethylbenzole
JPS5264415A (en) Preparation of solvent
IL49686A0 (en) Preparation of 3-phenoxybenzaldehydes
JPS5259118A (en) Preparation of trichloromethyll trifluoromethyllbenzene
ZA765403B (en) Derivatives of 2-substituted-hydroxyanilino-hexahydro-2h-benzo(alpha)quinolizines
JPS5259119A (en) Preparation of trichloromethyll trifluoromethyllbenzene
IL50634A0 (en) Preparation of 2-amino-1-alcohols
NZ181107A (en) 16-hydroxycarbyloxy-16-deacet-oxyfusidic acid derivatives and analogs thereof
JPS5277083A (en) Nnacyl derivatives of thienamycine
JPS5223028A (en) Preparation of alpha* alpha* alpha** alpha** alphaapentachlorooooxylol
JPS5271499A (en) Improvement of solubility of steviocide
IL50150A (en) Preparation of 3-methoxymethyl-cephalosporins
JPS5273832A (en) Preparation of halogennitrobenzole
NZ181026A (en) Preparation of n-oxazol-2-ylcarboxamides
JPS5262388A (en) Oligomerization of alphaaolefin
JPS51135228A (en) Preparation of leaffmold
PH13217A (en) Preparation of gamma-pyrones